期刊
SCIENCE CHINA-LIFE SCIENCES
卷 61, 期 4, 页码 373-379出版社
SCIENCE PRESS
DOI: 10.1007/s11427-017-9257-1
关键词
drug delivery; nanomedicine; obesity; browning; fat absorption; energy expenditure
类别
资金
- Sloan Research Fellowship
Obesity, as a chronic condition, has been a serious public health issue over the last decades both in the affluent Western world and developing countries. As reported, the risk of several serious diseases increases with weight gain, including type 2 diabetes, coronary heart disease, cancer, and respiratory diseases. In addition to lifestyle modifications, pharmacotherapy has become an important strategy to control weight gain. However, most of the anti-obesity drugs often show poor outcome for weight-loss and cause severe adverse effects. This review surveys recent advances in nanomedicine as an emerging strategy for obesity treatment with an emphasis on the enhanced therapeutic efficiency and minimized side effects. The insights for future development are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据